Zhengye Biotechnology Holding Limited
No trades
No trades
Fundamentals and stats
Financial statements, including revenue, expenses, and profit
The total revenue for the last semiannual is 7.58 M USD, and it's 11.72% lower compared to the previous semiannual. The net income of H2 25 is −6.75 M USD.
2021
2022
2023
2024
2025
Total revenue
Gross profit
Operating income
Pretax income
Net income
MetricsCurrency: USD
2021
2022
2023
2024
2025
TTM